Stamatia Laidou

6PUBLICATIONS
71CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Jan 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton

|Dec 24, 2022
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton

|Mar 02, 2022
The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.

Stamatia Laidou, Dionysios Grigoriadis, Sofia Papanikolaou

|Jul 12, 2021
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.

Stavroula Ntoufa, Marina Gerousi, Stamatia Laidou

Pageof 1

Frequent Collaborators

4 joint publications

Paolo Ghia

4 joint publications

Richard Rosenquist

4 joint publications

Rocío Benito

4 joint publications

Ana E Rodríguez-Vicente